The “Academician Independent Research Project” of the Spine and Spinal Cord Department at Kunming Tongren Hospital has successfully passed the project completion review
2026-06-27
Recently, the research project Treatment of Spinal Cord Injury Using Autologous Adipose-Derived Stromal Vascular Fraction, led by Academician Su Guohui and undertaken by Kunming Tongren Hospital, successfully passed the project completion review organized by the Kunming Municipal Bureau of Science and Technology. The expert review panel, comprising leading domestic scientists and clinical experts in cell research, including Academician Gu Xiaosong, spoke highly of the project, commenting that it “features innovation and groundbreaking achievements, fills the research gap in related fields in Yunnan Province, and has reached an internationally advanced level.”
This is the first “Academician Independent Exploration Project” launched in Kunming and the only medical research project among all projects in the program. The successful completion of the project marks a major breakthrough in the field of cell-based therapy for spinal cord injury.


From the very beginning of the project, the team set exceptionally high standards, demonstrating its professionalism in four key areas:
1. Strictly adhering to clinical guidelines to accurately identify clinical breakthroughs for the treatment of intractable diseases.
2. Benchmarking against international leading standards to achieve technological advancement.
3. Going beyond clinical observation to explore the underlying mechanisms in depth.
4. Adhering to international research standards to demonstrate the global value and broad applicability of the research.
Following breakthroughs in both clinical practice and scientific research, this technology has extended its impact beyond Kunming Tongren Hospital to the international stage, bringing new hope to patients with spinal cord injuries around the world.
After this technology achieved breakthroughs in both clinical practice and scientific research, its value has extended beyond Kunming Tongren Hospital onto a broader international stage, bringing new hope to spinal cord injury patients worldwide.
